Herpes simplex virus type 2 infection in a 5-year-old boy presenting with recurrent chest wall vesicles and a possible history of herpes encephalitis

British Journal of Dermatology

Volumn 137, Issue 3, 1997, Pages 440-444

  Tang, W Y M ^a   Lo, J Y C ^b   Yuen, M K ^c   Lam, W Y ^c  

^a Department of Community Medicine   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ATROPHY; CASE REPORT; CHILD; DISEASE TRANSMISSION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 2; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; SEXUAL ABUSE; SKIN BIOPSY; THORAX WALL; VIRUS CULTURE; VIRUS INFECTION;

EID: 0030825774     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03755.x     Document Type: Article

References (17)

1. Whitley RJ, Gnann JW Jr. The epidemiology and clinical manifestations of herpes simplex virus infections. In: The Human Herpesviruses (Roizman B, Whitley RJ, Lopez C, eds). New York: Raven Press, 1995: 69-105.
2. Schmidt NJ, Emmons RW. General principles of laboratory diagnostic methods for viral, rickettsial and chlamydial infections. In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections (Schmidt NJ, Emmons RW, eds). Washington DC: American Public Health Association, 1989: 1-35.
3. Ho DWT, Field PR, Irving WL, Packham DR, Cunningham AL. Detection of immunoglobulin M antibodies to glycoprotein G-2 by Western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol 1993; 31: 3157-64.
4. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990; 69: 19-36.
5. Gutman LT, Wilfert CM, Eppes S. Herpes simplex virus encephalitis in children: analysis of cerebrospinal fluid and progressive neurodevelopmental deterioration. J Infect Dis 1986; 154: 415-21.
6. Sullender WM, Miller JL, Yasukawa LL et al. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis 1987; 155: 28-37.
7. Thomas EE, Scheifele DW, MacLean BS. Herpes simplex type 2 aseptic meningitis in a two-month-old infant. Pediatr Infect Dis J 1989; 8: 184-6.
8. Silverman MS, Gartner JG, Halliday WC, Kohl S, Embree J. Persistent cerebrospinal fluid neutrophilia in delayed-onset neonatal encephalitis caused by herpes simplex virus type 2. J Pediatr 1992; 120: 567-9.
9. Do AN, Green PA. Herpes simplex virus type 2 meningitis and associated genital lesion in a three-year-old child. Pediatr Infect Dis J 1994; 13: 1014-16.
10. Ashley RA, Corey L. Herpes simplex viruses. In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections (Schmidt NJ, Emmons RW, eds). Washington DC: American Public Health Association, 1989: 265-317.
11. Kaplowitz LG, Baker D, Gelb L et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group. JAMA 1991; 265: 747-51.
12. Straus SE, Croen KD, Sawyer MH et al. Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment. JAMA 1988; 260: 2227-30.
13. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333: 770-5.
14. Dwyer DE, Cunningham AL. Herpes simplex virus infection in pregnancy. Baillières Clin Obstet Gynaecol 1993; 7: 75-105.
15. Skinner GR, Fink C, Melling J et al. Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis. Med Microbiol Immunol Berl 1992; 180: 305-20.
16. Mertz GJ, Ashley R, Burke RL et al. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J Infect Dis 1990; 161: 653-60.
17. Langenberg A, Burke RL, Adair SF et al. A recombinant glycoprotein vaccine for herpes simplex type 2: safety and efficacy. Ann Intern Med 1995; 122: 889-98.